Literature DB >> 2822763

Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization.

L A Campbell1, C C Kuo, J T Grayston.   

Abstract

Several molecular techniques were used for comparison of the novel Chlamydia agent, TWAR, with Chlamydia trachomatis and Chlamydia psittaci. Unlike all serotypes of C. trachomatis and most strains of C. psittaci, the eight TWAR isolates examined did not contain extrachromosomal DNA. TWAR was readily distinguished from C. trachomatis or C. psittaci by restriction endonuclease analysis, whereas identical or nearly identical restriction patterns were observed among the TWAR isolates. Southern blot analysis with a gene encoding a portion of the C. trachomatis serovar L2 major outer membrane protein as the probe showed that TWAR, like C. psittaci, contained sequences homologous to this gene. However, while the hybridization patterns were identical for all TWAR isolates, they differed from those of any of the other Chlamydia species tested. A PstI gene bank containing TWAR DNA was constructed in pUC19. Random fragments were purified and used for probing Chlamydia chromosomal digests. All of the five probes tested were TWAR specific, with the TWAR isolates showing identical patterns of homology. Qualitative studies of the DNA homology revealed that TWAR did not have significant homology to any of the Chlamydia strains assayed. Collectively, these results demonstrate that the TWAR isolates represent a single strain or closely allied genotypes and are clearly distinct from any of the other chlamydiae tested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822763      PMCID: PMC269366          DOI: 10.1128/jcm.25.10.1911-1916.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  OCCURENCE OF GLYCOGEN IN INCLUSIONS OF THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM-TRACHOMA AGENTS.

Authors:  F B GORDON; A L QUAN
Journal:  J Infect Dis       Date:  1965-04       Impact factor: 5.226

2.  GUINEA PIG INCLUSION CONJUNCTIVITIS VIRUS. I. ISOLATION AND IDENTIFICATION AS A MEMBER OF THE PSITTACOSIS-LYMPHOGRANULOMA-TRACHOMA GROUP.

Authors:  E S MURRAY
Journal:  J Infect Dis       Date:  1964-02       Impact factor: 5.226

3.  Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group).

Authors:  S P Dhir; S Hakomori; G E Kenny; J T Grayston
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  A rapid boiling method for the preparation of bacterial plasmids.

Authors:  D S Holmes; M Quigley
Journal:  Anal Biochem       Date:  1981-06       Impact factor: 3.365

5.  Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.

Authors:  E Y Chi; C C Kuo; J T Grayston
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

6.  Antigenic diversity of Chlamydia psittaci of mammalian origin determined by microimmunofluorescence.

Authors:  J A Perez-Martinez; J Storz
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

7.  Molecular characterization of Chlamydia trachomatis and Chlamydia psittaci plasmids.

Authors:  T Joseph; F E Nano; C F Garon; H D Caldwell
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

9.  Lymphogranuloma venereum. II. Characterization of some recently isolated strains.

Authors:  J Schachter; K F Meyer
Journal:  J Bacteriol       Date:  1969-09       Impact factor: 3.490

10.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  34 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Two-step polymerase chain reactions and restriction endonuclease analyses detect and differentiate ompA DNA of Chlamydia spp.

Authors:  B Kaltenboeck; K G Kousoulas; J Storz
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection.

Authors:  D Michel; J C Antoine; B Pozzetto; O G Gaudin; F Lucht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

4.  The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.

Authors:  Zhongyu Li; Ding Chen; Youmin Zhong; Shiping Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

5.  Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog.

Authors:  J M Kornak; C C Kuo; L A Campbell
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

6.  Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans.

Authors:  L A Campbell; C C Kuo; R W Thissen; J T Grayston
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

7.  Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium.

Authors:  L Van Renterghem; A M Van den Abeele; G Claeys; J Plum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

8.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Structural and antigenic analysis of Chlamydia pneumoniae.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.